| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥3.05B | +0.5% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.02B | — |
| Gross margin | 0.9% | Net margin 0.7% |
| Revenue Q/Q | +10.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.02B | 99.1% |
| R&D | ¥0.01B | 0.2% |
| SG&A | ¥0.03B | 0.9% |
| Tax & other | ¥-0.01B | -0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
深城交 ・ 争光股份 ・ 华兰股份 ・ 广立微 ・ 百诚医药 ・ 天益医疗 ・ 金埔园林 ・ 雅创电子 ・ 风光股份 ・ 明月镜片 ・ 兆讯传媒 ・ 何氏眼科
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies